John O’Reilly, the Director General for Knowledge and Innovation at the Department for Business, Innovation & Skills (BIS) requested views and comments on the key priorities and challenges for the science and research budget in forthcoming spending decisions for the 2015 to 2016 financial year.
The Society responded to highlight the importance of investment in drug discovery.
Read our response
Published: 17 May 2013 in